Literature DB >> 14528326

[Arterial hypertension in Ilha do Governador, Rio de Janeiro, Brazil: I. Methodology].

C H Klein1, N A Silva, A R Nogueira, K V Bloch, L H Campos.   

Abstract

The aim of this paper (first of a series of two) is to present the main methodological aspects used in a cross-sectional study whose proposals were to establish the prevalence of arterial hypertension in adults in Ilha do Governador (a district of the city of Rio de Janeiro, Brazil), and to examine its relationship to other risk factors, including those for cardiovascular diseases, so as to establish its control status. Sampling design (of clusters in strata, according to mean household income) is described in detail, in addition to measurement methods, and training of observers. Indicators of performance in field work and quality control are also presented as results of the application of the metodology of study.

Entities:  

Year:  2003        PMID: 14528326     DOI: 10.1590/s0102-311x1995000200003

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  3 in total

1.  Evolution of Cardiovascular Diseases Mortality in the Counties of the State of Rio de Janeiro from 1979 to 2010.

Authors:  Gabriel Porto Soares; Carlos Henrique Klein; Nelson Albuquerque de Souza e Silva; Glaucia Maria Moraes de Oliveira
Journal:  Arq Bras Cardiol       Date:  2015-03-17       Impact factor: 2.000

2.  Cardiovascular mortality among a cohort of hypertensive and normotensives in Rio de Janeiro - Brazil - 1991-2009.

Authors:  Thiago Luiz Nogueira da Silva; Carlos Henrique Klein; Armando da Rocha Nogueira; Lucia Helena Alvares Salis; Nelson Albuquerque de Souza E Silva; Katia Vergetti Bloch
Journal:  BMC Public Health       Date:  2015-07-08       Impact factor: 3.295

Review 3.  Hypertension control in brazilian publications.

Authors:  Natália de Alencar Pinho; Angela Maria Geraldo Pierin
Journal:  Arq Bras Cardiol       Date:  2013-09       Impact factor: 2.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.